Random-start Ovarian Stimulation in Egg-donors (ROSE)

• Status: Terminated
• Trial end date: 2018-01-12
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this prospective single-center study is to evaluate the laboratory outcome after random start ovarian stimulation in oocyte donors. The study will be performed in egg-donors but this type of treatment has the potential to be implemented in general infertility population.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Instituto Bernabeu
• Treatments: Cetrorelix; Deslorelin; Prolactin Release-Inhibiting Factors; Triptorelin Pamoate

Criteria

Inclusion Criteria:

• Premenopausal women

• 18-35 years old

• FSH levels < 10 IU/liter

• Antral follicle count (AFC) > 10

• Regular cycles

• Body Mass Index (BMI) < 28

• Signed informed consent

Exclusion Criteria:

• Polycystic ovary syndrome (PCOS) patients

• Allergy to gonadotrophins

• Concomitant participation in other trial